Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Intern Med ; 261(1): 91-100, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17222172

RESUMO

BACKGROUND: Nontyphoid Salmonella (NTS) isolates lead to not only self-limited, acute gastrointestinal infections, but also bacteraemia with or without extraintestinal focal infections (EFIs). The risk factors associated with EFIs in adults with NTS bacteraemia were not clearly elucidated. METHODS: In a medical center in southern Taiwan, patients aged > or = 18 years with NTS bacteraemia between January 1999 and June 2005 were included for analysis. RESULTS: Of 129 patients, 51 (39.5%) were complicated with EFIs. The most common EFI was mycotic aneurysm, followed by pleuropulmonary infections and spinal osteomyelitis. Compared to patients with primary bacteraemia, those with EFIs had higher leucocyte counts (P = 0.004) and higher serum levels of C-reactive protein (P < 0.0001). The development of EFIs was associated with a higher mortality, more severe septic manifestations, longer hospital stays and duration of antimicrobial therapy. Univariate analysis revealed that diabetes mellitus (P = 0.02), hypertension (P = 0.02) and chronic lung disease (P = 0.006) were significantly associated with EFIs. However, patients with malignancy (P = 0.01) and immunosuppressive therapy (P = 0.03) were less likely to develop EFIs. On the basis of multivariate analysis, an independent factor for the occurrence of EFIs was age [adjusted odds ratio (aOR) 1.05; 95% confidence interval (CI) 1.02-1.07; P < 0.0001], whilst malignancy was negatively associated with EFIs (aOR 0.16; 95% CI 0.14-0.78; P = 0.01). CONCLUSION: Amongst patients with NTS bacteraemia, EFIs often occurred in the aged, and were associated with a higher mortality and morbidity. Recognition of specific host factors is essential for identification of EFIs which often demand early surgical interventions and prolonged antimicrobial therapy.


Assuntos
Infecção Focal/diagnóstico , Infecções por Salmonella/diagnóstico , Adulto , Idoso , Aneurisma Infectado/diagnóstico , Aneurisma Infectado/tratamento farmacológico , Aneurisma Infectado/mortalidade , Antibacterianos/uso terapêutico , Bacteriemia/diagnóstico , Bacteriemia/tratamento farmacológico , Bacteriemia/mortalidade , Farmacorresistência Bacteriana , Métodos Epidemiológicos , Feminino , Febre/microbiologia , Infecção Focal/tratamento farmacológico , Infecção Focal/mortalidade , Humanos , Pneumopatias/diagnóstico , Pneumopatias/tratamento farmacológico , Pneumopatias/mortalidade , Masculino , Pessoa de Meia-Idade , Osteomielite/diagnóstico , Osteomielite/tratamento farmacológico , Osteomielite/mortalidade , Infecções por Salmonella/tratamento farmacológico , Infecções por Salmonella/mortalidade , Choque Séptico/diagnóstico , Taiwan/epidemiologia , Resultado do Tratamento
2.
Kansenshogaku Zasshi ; 75(11): 981-8, 2001 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-11766382

RESUMO

We report an 8-year-old boy with acute focal bacterial nephritis (AFBN). At the age of 3 months, he had a history of urinary tract infection and vesicoureteral reflux. He was admitted to our hospital because of high fever and costovertebral angle pain. Although acute pyelonephritis was suspected, neither pyuria nor cultures of blood and urine were positive. An initial ultrasonogram (US) of his kidneys was normal except for bilateral hydronephrosis. Two days later, however, a computed tomography (CT) revealed a poorly enhanced mass in the upper pole of the right kidney. Similar findings were also observed by US. Under the diagnosis of AFBN, he received antibiotics for 3 weeks. Voiding cystourethrogram showed both-sided vesicoureteral reflux and he underwent an operation. At present the mass of the kidney still remains, albeit its size tends to decrease. We suggest that an early examination of US or enhanced CT is necessary in cases with fever of unknown origin, considering the possibility of AFBN even if neither pyuria nor cultures of urine are positive.


Assuntos
Infecções Bacterianas/diagnóstico , Infecção Focal/diagnóstico , Nefrite/diagnóstico , Doença Aguda , Infecções Bacterianas/diagnóstico por imagem , Infecções Bacterianas/microbiologia , Criança , Infecção Focal/diagnóstico por imagem , Infecção Focal/mortalidade , Humanos , Masculino , Nefrite/diagnóstico por imagem , Nefrite/microbiologia , Tomografia Computadorizada por Raios X , Ultrassonografia , Infecções Urinárias/complicações , Refluxo Vesicoureteral/complicações
3.
Infection ; 20(4): 207-12, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1521886

RESUMO

Severe focal viral encephalitis is most commonly caused by herpes simplex virus (HSV), but other viruses may act as etiologic agents as well. Acyclovir (ACV) is the standard therapy for HSV encephalitis, but the mortality of 28% and defect healing rate of about 35% are still unsatisfactory. Furthermore, ACV has virtually no effect on other pathogens of viral encephalitis, except for varicella-zoster virus (VZV). It is well known that beta-interferon (beta-IFN) has a broad antiviral spectrum, and it has been demonstrated in vitro that beta-IFN in combination with acyclovir has synergistic inhibitory effects on HSV. To investigate if the combination of ACV with and without beta-IFN might also be of significance for the treatment of severe viral encephalitis, we performed a retrospective study. A case record form was sent to all 278 West German children's hospitals. The response rate was 78%. A total of 301 patients were reported, of whom 214 received specific antiviral therapy with either ACV alone (n = 179) or ACV plus beta-IFN (n = 35). No overall differences between ACV monotherapy and the combination therapy were observed. However, in a subgroup of 41 patients (ACV n = 30, ACV plus beta-IFN n = 11) who had low-density areas of the temporal lobes on cranial computed tomography scans, compatible with severe focal encephalitis, sequelae due to defect formation and mortality were significantly (p = 0.014) reduced in patients who had received combination therapy.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Aciclovir/uso terapêutico , Encefalite/tratamento farmacológico , Infecção Focal/tratamento farmacológico , Herpes Simples/tratamento farmacológico , Interferon beta/uso terapêutico , Aciclovir/administração & dosagem , Aciclovir/farmacologia , Criança , Pré-Escolar , Terapia Combinada , Sinergismo Farmacológico , Encefalite/diagnóstico por imagem , Encefalite/mortalidade , Feminino , Infecção Focal/diagnóstico por imagem , Infecção Focal/mortalidade , Alemanha/epidemiologia , Herpes Simples/diagnóstico por imagem , Herpes Simples/mortalidade , Hospitais Pediátricos , Humanos , Lactente , Interferon beta/administração & dosagem , Interferon beta/farmacologia , Masculino , Estudos Retrospectivos , Tomografia Computadorizada por Raios X , Resultado do Tratamento
4.
Chirurg ; 63(3): 174-80, 1992 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-1559398

RESUMO

The therapeutical concept of programmed relaparotomy was performed in 184 patients with diffuse peritonitis from 4/1984 to 4/1991. Clinical results were prospectively documented and a total of 46 variables (e.g. risk factors, clinical parameters, laboratory tests, microbiological screenings, score systems) both univariate and multivariate were tested for prognostic significance. Total lethality rate was 26% (48/184 patients). If complete eradication of the source of infection was surgically achieved (150 patients/82%) lethality rate was only 9%. In contrast, lethality rate was 100% in patients with unsuccessful surgical focus eradication. Eradication of the source of infection during the first operation (104 patients/56%) resulted in a lethality rate of 6%, compared to 17% for patients who needed two or even more operations (46 patients/25%). Eradication of the source of infection during the first laparotomy ("focus eradication on time") was the most important prognostic parameters. Of further prognostic significance but with declining importance where serum-creatinine at the beginning of the treatment, patient's age (greater than less than 70 years) and preexistent hepatic disease.


Assuntos
Laparotomia , Peritonite/cirurgia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Infecção Focal/epidemiologia , Infecção Focal/mortalidade , Infecção Focal/cirurgia , Humanos , Laparotomia/efeitos adversos , Laparotomia/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Insuficiência de Múltiplos Órgãos/epidemiologia , Análise Multivariada , Peritonite/epidemiologia , Peritonite/mortalidade , Complicações Pós-Operatórias/epidemiologia , Prognóstico , Análise de Regressão , Reoperação/efeitos adversos , Reoperação/estatística & dados numéricos , Fatores de Risco , Índice de Gravidade de Doença , Fatores de Tempo
5.
Artigo em Russo | MEDLINE | ID: mdl-1441815

RESUMO

The influence of dimephosphone at concentrations of 0.001 M-0.75 M on the chemiluminescence of tissues at the focus of purulent infection in the ear of a guinea pig, on the survival rate of the experimental animals injected with the lethal dose of Staphylococcus aureus, as well as on the spontaneous and stimulated chemiluminescence of blood neutrophils in patients with wound infection, was studied. The study showed that different concentrations of dimephosphone oppositely influenced the intensity of the chemiluminescence of neutrophil suspensions and tissues at the focus of infection: low concentrations were found to produce stimulating action and high concentrations, suppressive action. At the highest concentration used in this study (0.75 M) dimephosphone prevented the death of the animals receiving lethal doses of S. aureus.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Infecção Focal/tratamento farmacológico , Medições Luminescentes , Neutrófilos/efeitos dos fármacos , Compostos Organofosforados/uso terapêutico , Infecções Cutâneas Estafilocócicas/tratamento farmacológico , Animais , Células Cultivadas/efeitos dos fármacos , Células Cultivadas/metabolismo , Distribuição de Qui-Quadrado , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Infecção Focal/metabolismo , Infecção Focal/mortalidade , Cobaias , Humanos , Masculino , Neutrófilos/metabolismo , Infecções Cutâneas Estafilocócicas/metabolismo , Infecções Cutâneas Estafilocócicas/mortalidade , Infecção dos Ferimentos/tratamento farmacológico , Infecção dos Ferimentos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...